Gerhard I, Lenhard H K, Eggert-Kruse W, Runnebaum B
University of Heidelberg, Department of Gynecological Endocrinology, Germany.
Arch Androl. 1991 Nov-Dec;27(3):129-47. doi: 10.3109/01485019108987664.
The recognition that discreet hormonal abnormalities may cause ovulation disorders in women suggested that the male partner of infertile women might also suffer from unrecognized hormonal dysfunction amendable to substitution therapy. We obtained a combined stimulation test with gonadotropin-releasing hormone (GnRH), thyreotropin-releasing hormone (TRH), and ACTH in 225 males with childless spouses, when the couple sought to have children for at least one year. The following hormone levels were determined: estradiol (E), thyroid-stimulating hormone (TSH), prolactin, testosterone (T), dihydrotestosterone (DHT), androstenedione(A), 17-OH-pregnenolone (17-OH-Preg), 17-OH-progesterone (17-OHP), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), cortisone (F), and 21-desoxycortisone (21DF). Basal and stimulated, and adrenal-testicular steroids with and without ACTH stimulation failed to demonstrate a relevant relationship to semen parameters. Gonadotropin levels had a significant negative correlation to all important semen parameters (testicular volume, sperm count, motility, morphology, and vitality) and were positively correlated to spermiogenetic defects. Stimulated LH values were more clearly associated with spermiogenetic defects than basal LH. Nonetheless, basal FSH concentrations were more informative than LH. Stimulated prolactin values were positively correlated with both gonadotropin and with sperm morphology. E concentrations had a significant positive correlation with both basal and poststimulation DHEAS values, and showed a highly negative correlation with sperm count, morphology, and vitality. In comparison, good sperm parameters were associated with high poststimulation T concentrations. The results of this study suggest that basal FSH and E concentrations, as well as the stimulated LH, T, and prolactin determinations, should be included in the evaluation of male sterility.
认识到细微的激素异常可能导致女性排卵障碍,这表明不育女性的男性伴侣也可能存在未被识别的激素功能障碍,适合进行替代疗法。当夫妇双方试图生育至少一年时,我们对225名配偶不育的男性进行了促性腺激素释放激素(GnRH)、促甲状腺激素释放激素(TRH)和促肾上腺皮质激素(ACTH)联合刺激试验。测定了以下激素水平:雌二醇(E)、促甲状腺激素(TSH)、催乳素、睾酮(T)、双氢睾酮(DHT)、雄烯二酮(A)、17-羟孕烯醇酮(17-OH-Preg)、17-羟孕酮(17-OHP)、脱氢表雄酮(DHEA)、硫酸脱氢表雄酮(DHEAS)、可的松(F)和21-脱氧可的松(21DF)。基础和刺激后的肾上腺-睾丸类固醇,无论有无ACTH刺激,均未显示与精液参数有相关关系。促性腺激素水平与所有重要的精液参数(睾丸体积、精子计数、活力、形态和活力)呈显著负相关,与精子发生缺陷呈正相关。刺激后的LH值比基础LH值与精子发生缺陷的关联更明显。尽管如此,基础FSH浓度比LH更具信息量。刺激后的催乳素值与促性腺激素和精子形态均呈正相关。E浓度与基础和刺激后DHEAS值均呈显著正相关,与精子计数、形态和活力呈高度负相关。相比之下,良好的精子参数与刺激后高T浓度相关。本研究结果表明,基础FSH和E浓度,以及刺激后的LH、T和催乳素测定结果,应纳入男性不育症的评估中。